EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Nature Medicine2011Vol. 17(5), pp. 589–595
Citations Over TimeTop 1% of 2011 papers
Joachim Lupberger, Mirjam B. Zeisel, Fei Xiao, Christine Thumann, Isabel Fofana, Laetitia Zona, Christopher Davis, Christopher Mee, Marine Turek, Sebastian Gorke, Cathy Royer, Benoit Fischer, Muhammad Zahid, Dimitri Lavillette, Judith Fresquet, François–Loïc Cosset, S. Michael Rothenberg, Thomas Pietschmann, Arvind H. Patel, Patrick Pessaux, Michel Doffoël, Wolfgang Raffelsberger, Olivier Poch, Jane A. McKeating, Laurent Brino, Thomas F. Baumert
Related Papers
- → Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry(2007)1,185 cited
- → High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets(2004)119 cited
- → Conservation and Early Expression of Zebrafish Tyrosine Kinases Support the Utility of Zebrafish as a Model for Tyrosine Kinase Biology(2012)21 cited
- → Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently-Infected Huh7 Cultures(2013)6 cited
- → Abstract PL04-03: Cell signaling by receptor tyrosine kinases: From basic principles to cancer therapy(2012)1 cited